Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,113 | 10,700 | 12,709 | 5,174 | 3,705 |
| TOTAL | $14,206 | $10,812 | $12,832 | $5,360 | $3,928 |
| Non-Current Assets | |||||
| PPE Net | 141 | 18 | 24 | 35 | 42 |
| Other Non-Current Assets | 698 | 753 | 0 | 0 | 0 |
| TOTAL | $838 | $771 | $24 | $35 | $42 |
| Total Assets | $15,044 | $11,583 | $12,856 | $5,395 | $3,970 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 828 | 578 | 1,035 | 829 | 625 |
| Accrued Expenses | 468 | 1,398 | 819 | 740 | 464 |
| Other current liabilities | N/A | N/A | 0 | 1 | 1 |
| TOTAL | $1,417 | $1,998 | $1,855 | $1,569 | $1,090 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 638 | 724 | 0 | 0 | 0 |
| TOTAL | $638 | $724 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,055 | $2,722 | $1,855 | $1,569 | $1,090 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,908 | 3,720 | 1,481 | 425 | 80 |
| Common Shares | 4 | 2 | 4 | 2 | 1 |
| Retained earnings | -52,428 | -49,419 | -46,908 | -45,001 | -42,557 |
| TOTAL | $12,989 | $8,861 | $11,002 | $3,826 | $2,881 |
| Total Liabilities And Equity | $15,044 | $11,583 | $12,856 | $5,395 | $3,970 |